Takeda Pharmaceutical Company Limited (TKDA) - Total Liabilities

Latest as of December 2025: €7.76 Trillion EUR ≈ $9.08 Trillion USD

Based on the latest financial reports, Takeda Pharmaceutical Company Limited (TKDA) has total liabilities worth €7.76 Trillion EUR (≈ $9.08 Trillion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore TKDA year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Takeda Pharmaceutical Company Limited - Total Liabilities Trend (2017–2025)

This chart illustrates how Takeda Pharmaceutical Company Limited's total liabilities have evolved over time, based on quarterly financial data. See Takeda Pharmaceutical Company Limited (TKDA) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Takeda Pharmaceutical Company Limited Competitors by Total Liabilities

The table below lists competitors of Takeda Pharmaceutical Company Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Banco Bradesco DRC BA:BBD	Argentina	AR$2.03 Trillion
Samsung Biologics Co Ltd KO:207940	Korea	₩6.16 Trillion
Coca-Cola European Partners PLC NASDAQ:CCEP	USA	$23.28 Billion
Shanghai Pudong Development Bank Co Ltd SHG:600000	China	CN¥9.46 Trillion
IDEXX Laboratories Inc NASDAQ:IDXX	USA	$1.83 Billion
Ambev S.A. F:AMNA	Germany	€56.31 Billion
Yageo Corp TW:2327	Taiwan	NT$232.60 Billion
STANDARD CHART.UNSP.ADR/2 F:STD0	Germany	€918.22 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Takeda Pharmaceutical Company Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Takeda Pharmaceutical Company Limited market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.19	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.50	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Takeda Pharmaceutical Company Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Takeda Pharmaceutical Company Limited (2017–2025)

The table below shows the annual total liabilities of Takeda Pharmaceutical Company Limited from 2017 to 2025.

Year	Total Liabilities	Change
2025-03-31	€7.31 Trillion ≈ $8.55 Trillion	-6.67%
2024-03-31	€7.83 Trillion ≈ $9.16 Trillion	+3.05%
2023-03-31	€7.60 Trillion ≈ $8.89 Trillion	+1.45%
2022-03-31	€7.49 Trillion ≈ $8.76 Trillion	-3.11%
2021-03-31	€7.74 Trillion ≈ $9.04 Trillion	-4.43%
2020-03-31	€8.09 Trillion ≈ $9.46 Trillion	-7.06%
2019-03-31	€8.71 Trillion ≈ $10.18 Trillion	+316.87%
2018-03-31	€2.09 Trillion ≈ $2.44 Trillion	-13.20%
2017-03-31	€2.41 Trillion ≈ $2.81 Trillion	--

About Takeda Pharmaceutical Company Limited

F:TKDA Germany Drug Manufacturers - Specialty & Generic

Market Cap

$54.66 Billion

€46.76 Billion EUR

Market Cap Rank

#622 Global

#127 in Germany

Share Price

€14.80

Change (1 day)

+0.00%

52-Week Range

€11.30 - €16.10

All Time High

€16.10